![]() |
|
|
Vol. 282, Issue 1, 496-504, 1997
2 in Activation of
Mitogen-Activated Protein Kinase and Phospholipase A2 by
Zooxanthellatoxin-A in Rabbit Platelets1
Department of Pharmaceutical Molecular Biology, Zooxanthellatoxin-A (ZT-A), a polyhydroxypolyene isolated from a
symbiotic dinoflagellate Symbiodinium sp., caused
thromboxane A2-(TXA2) dependent and
genistein-sensitive aggregation in rabbit platelets. Our study was
performed to clarify the mechanism of the action of ZT-A. ZT-A caused
an increase in tyrosine phosphorylation of 42-kDa protein, which is
defined as p42 mitogen-activated protein kinase (MAPK) by
immunoprecipitation. Although indomethacin (10 µM) completely
inhibited ZT-A-induced TXB2 release, it partially inhibited
the MAPK activation. The remained MAPK activation was completely
inhibited by genistein (50 µM). Genistein (50 µM), by itself,
abolished TXB2 release induced by ZT-A. ZT-A (2 µM) stimulated liberation of arachidonic acid and the subsequent
metabolites such as TXB2 and 12-hydroperoxyeicosatetraenoic
acid. However, ZT-A-stimulated phosphoinositide hydrolysis which was
due to an increase in tyrosine phosphorylation of phospholipase
C-(PLC)
2. The phosphorylation of PLC-
2 and the phosphoinositide
hydrolysis were also partially inhibited by indomethacin (10 µM), and
were abolished by a combined treatment of indomethacin (10 µM) and genistein (50 µM). ZT-A- (2 µM) induced MAPK activation in the presence of indomethacin (10 µM) was concentration-dependently inhibited by staurosporine and calphostin C, protein kinase C inhibitors. PD98059 (50 µM), a MAPK kinase inhibitor, also inhibited ZT-A-induced TXB2 release. Depletion of external
Ca++ abolished ZT-A- (2 µM) induced MAPK activation,
phosphoinositide hydrolysis, arachidonic acid liberation and
TXB2 release. These results suggest that ZT-A stimulates a
protein tyrosine kinase in the presence of external Ca++,
resulting in the activation of MAPK probably via PLC-
2 and protein
kinase C. The MAPK stimulated a liberation of arachidonic acid that is
rapidly converted to TXA2. The released TXA2
causes aggregation accompanied with second stimulation of MAPK cascade.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics